NICE Taxonomy

  1. e-entropy USE consciousness monitors
  2. ear and nose
  3. ear surgery
  4. ear, nose and oropharynx (drug treatments)
  5. ear, nose and throat surgery USE otolaryngology
  6. early years centres USE nursery schools
  7. eating behaviour USE healthy eating
  8. eating disorders
  9. economic appraisal
  10. economically deprived people USE low income people
  11. ect USE electroconvulsive therapy
  12. ectopic pregnancy
  13. eczema
  14. education
  15. education settings
  16. education staff
  17. efalizumab
  18. efcortelan USE hydrocortisone
  19. effectiveness
  20. efient USE prasugrel
  21. efm USE fetal monitoring
  22. EGFR mutation USE epidermal growth factor recepter mutation
  23. elderly USE older people
  24. electric stimulation USE deep brain stimulation
  25. electroconvulsive therapy
  26. electroencephalography monitoring USE consciousness monitors
  27. electroencephalography monitors USE consciousness monitors
  28. electronic fetal monitoring USE fetal monitoring
  29. electronic foetal monitoring USE fetal monitoring
  30. electrosurgery devices
  31. electrosurgery procedures
  32. elidel USE pimecrolimus
  33. eliquis USE apixaban
  34. elocon USE mometasone furoate
  35. eloxatin USE oxaliplatin
  36. eltrombopag
  37. elucigene fh20 USE genetic testing devices
  38. embolisation
  39. embolism
  40. embolization USE embolisation
  41. emergency medicine
  42. emergency services staff
  43. emeside USE ethosuximide
  44. emollient and barrier preparations
  45. emotional depression USE depression
  46. emphysema
  47. employed USE employees
  48. employee representatives
  49. employees
  50. employers
  51. employment
  52. employment group
  53. enalapril maleate
  54. enbrel USE etanercept
  55. endocarditis
  56. endocrine system (drug treatments)
  57. endocrine system and breast surgery
  58. endocrine, nutritional and metabolic
  59. endocrinology
  60. endometrial cancer
  61. endometrioma USE endometriosis
  62. endometriosis
  63. endometriosis externa USE endometriosis
  64. endoscope USE endoscopes
  65. endoscopes
  66. endoscopy
  67. endotracheal intubation USE airway management
  68. engagement of carers USE patient and public involvement
  69. engagement of consumers USE patient and public involvement
  70. engagement of patients USE patient and public involvement
  71. engagement of service users USE patient and public involvement
  72. engagement of the public USE patient and public involvement
  73. engagement of users USE patient and public involvement
  74. engaging carers USE patient and public involvement
  75. engaging consumers USE patient and public involvement
  76. engaging patients USE patient and public involvement
  77. engaging patients and carers USE patient and public involvement
  78. engaging patients and the public USE patient and public involvement
  79. engaging service users USE patient and public involvement
  80. engaging the public USE patient and public involvement
  81. engaging users USE patient and public involvement
  82. ent surgery USE otolaryngology
  83. entecavir
  84. entertainment venues
  85. environment
  86. environmental impact assessment
  87. epanutin USE phenytoin
  88. epath USE evaluation pathway programme for medical technologies
  89. epidermal growth factor recepter mutation
  90. epilepsia USE epilepsy
  91. epilepsies USE epilepsy
  92. epilepsy
  93. epilim USE valproate
  94. episenta USE valproate
  95. epival USE valproate
  96. eptifibatide
  97. erbitux USE cetuximab
  98. eribulin
  99. erlotinib
  100. erythropoietin
  101. eslicarbazepine USE eslicarbazepine acetate
  102. eslicarbazepine acetate
  103. esophageal doppler monitor USE oesophageal doppler monitors
  104. etanercept
  105. ethnic groups
  106. ethnicity
  107. ethosuximide
  108. etodolac
  109. eumovate USE clobetasone butyrate
  110. evaluation
  111. evaluation pathway programme for medical technologies
  112. evaluation pathways USE evaluation pathway programme for medical technologies
  113. everolimus
  114. evita open plus USE cardiothoracic devices
  115. excluded groups USE vulnerable groups
  116. excluded people USE vulnerable groups
  117. excluded person USE vulnerable groups
  118. exelon USE rivastigmine
  119. exenatide
  120. exercise
  121. exjade USE deferasirox
  122. exogen USE bone healing devices
  123. exogen bone healing system USE bone healing devices
  124. expectant parents
  125. experiences of carers USE patient and public involvement
  126. experiences of consumers USE patient and public involvement
  127. experiences of patients USE patient and public involvement
  128. experiences of service users USE patient and public involvement
  129. experiences of the public USE patient and public involvement
  130. experiences of users USE patient and public involvement
  131. eye
  132. eye (drug treatments)
  133. eye surgery
  134. ezetimibe
  135. ezetrol USE ezetimibe